What Is a Divestiture? Definition, Types, Strategy, and Real Examples (2026)

What Is a Divestiture? Definition, Types, Strategy, and Real Examples (2026)

Last updated: August 2026

Quick answer. A divestiture is the sale or disposal of a business unit, subsidiary, or asset — usually for cash — to a strategic acquirer or a private-equity buyer. Cash comes in to the parent; the business leaves its ownership. That is what separates a divestiture from a spin-off, where no cash changes hands and the same shareholders keep the business as a new stock. Divestitures take several forms (trade sale, carve-out sale to a PE sponsor, liquidation, and forced antitrust-remedy sales), and they run on a sell-side process: perimeter, carve-out financials, TSAs, CIM, buyer diligence, and an SPA. Recent examples are all cash sales: Sanofi → Opella to CD&R (€16.0B EV, closed April 30, 2025), Intel → Altera 51% to Silver Lake ($4.46B, closed September 12, 2025), and Reckitt → Essential Home 70% to Advent ($4.8B EV, closed December 31, 2025).

I'm Chris Chen. Before joining Peony, I worked in M&A at Moelis & Company across cross-border, healthcare, industrials, and consumer transactions. Divestitures and carve-outs are where banking teams actually earn their fee — a clean whole-company sale is one thing, but surgically extracting a division that shares systems, staff, and financials with its parent is where the real work lives. The vocabulary around all of this is abused constantly in the press: "divest," "spin-off," and "carve-out" get used as synonyms when they describe transactions with completely different cash flows and owners. This post is the sale-side map. If you want the no-cash side — pro-rata distributions, split-offs, and the tax rules — that lives in our spin-off guide, and I'll point you there rather than repeat it.

What is a divestiture?

A divestiture is the sale or disposal of a business unit, subsidiary, product line, or asset, usually for cash, to a buyer. Two features define it: money flows in to the selling parent, and the divested business leaves the parent's ownership entirely. Whoever buys it — a competitor pursuing scale (a strategic buyer) or a private-equity firm building a platform (a financial buyer) — now owns and runs the business. The parent walks away with proceeds and a narrower portfolio.

That "cash in, business out" shape is the anchor, because it is exactly what separates a divestiture from the transactions it gets confused with. A divestiture is not a distribution to your own shareholders and not a stock swap; it is a sale to an outside buyer, the same way you would sell any other asset — just at the scale of an entire operating division.

The most recent large examples make the mechanic concrete. In 2025, Sanofi sold a 50% controlling stake in its consumer-health business Opella to the private-equity firm Clayton, Dubilier & Rice (CD&R), a deal built on a €16.0 billion enterprise value that closed April 30, 2025 and netted Sanofi roughly €10 billion in cash. Intel sold a 51% stake in Altera, its programmable-chip unit, to Silver Lake for $4.46 billion at an $8.75 billion valuation, closing September 12, 2025. In both cases a buyer wrote a check, the parent booked proceeds, and control of the unit changed hands. That is a divestiture.

What is the difference between divestiture and divestment?

Divestment is the broad umbrella; divestiture is the specific corporate transaction inside it. The two words are close cousins and get swapped freely, but they are not the same size. "Divestment" covers any act of shedding an asset — including things that are not deals at all. "Divestiture" is the M&A event: the sale of a business unit for cash.

The clearest way to see the gap is the ESG and portfolio meaning of divestment. When a pension fund sells its holdings in a fossil-fuel company, or a university endowment exits an entire sector on principle, that is divestment — a portfolio decision, executed by selling securities on the open market. No business unit is sold, no buyer negotiates a purchase agreement, and no company loses a division. It is a rebalancing driven by returns or values.

A divestiture, by contrast, is a negotiated transaction: a parent company sells a division, subsidiary, or product line to an identified buyer under a sale and purchase agreement. So every divestiture is a form of divestment, but most divestment — an investor dumping a stock — is not a divestiture. A useful rule: if a specific business changes hands to a specific buyer, it is a divestiture; if an investor is simply exiting a position, it is portfolio divestment. This post is about the first kind.

What are the types of divestitures?

There are six structural routes a company can take to divest — plus one special case, the regulator-forced sale — and they differ on the two axes that matter: does cash come in, and who ends up owning the business. Three of them raise cash from a buyer; the others hand the business to shareholders or shut it down. The table sorts the family, and the notes below take each route sale-side first.

• Trade sale (sell-off). The parent sells the unit outright to a strategic buyer — typically a competitor or an adjacent company pursuing scale — for cash. This is the plainest divestiture: one buyer, one purchase agreement, full transfer of ownership. It is the fastest route to certain cash when a clean buyer exists.
• Carve-out sale to a private-equity sponsor. The parent sells an embedded business unit — one that shared systems, staff, and financials with the parent — to a PE firm that will run it as a standalone platform. This is harder than a trade sale of a self-contained subsidiary because the unit has to be surgically separated first (more on that in the process section).
• Equity carve-out (IPO of a minority stake). The parent floats a minority stake in the unit through an IPO, raising cash while usually keeping control. Because the mechanics overlap with the spin-off family, the spin-off guide covers the equity-carve-out route in detail.
• Spin-off. The parent distributes the unit's shares pro-rata to existing shareholders for no cash, creating a separate public company. No buyer, no proceeds. Covered fully in the spin-off guide.
• Split-off. An elective share exchange: shareholders can swap parent shares for subsidiary shares. Also a no-cash structure, and also covered in the spin-off guide.
• Liquidation or wind-down. When no buyer will pay a worthwhile price, the parent sells the assets piecemeal and shuts the unit. Proceeds come from asset sales rather than a going-concern buyer; it is the exit of last resort.
• Regulatory-remedy divestiture. A forced sale required by antitrust authorities to clear a larger merger. The parties do not choose to divest — they must, to win approval. Covered in its own section below.

Read that list against the two axes and the family sorts itself: trade sale, carve-out sale, and equity carve-out all raise cash; spin-off and split-off do not; liquidation raises cash but ends the business; and the antitrust-remedy sale is the one case where the seller has no choice. For a side-by-side of the no-cash structures, the spin-off post carries the full table.

Why do companies divest?

Companies divest to redeploy value — the common thread across every motive is that a unit is worth more sold, or the parent is worth more without it. The reasons cluster into a few durable themes, and they are qualitative; there is no single statistic that captures why boards decide to sell.

The first is focus. Shedding a non-core division lets management concentrate capital and attention on the core, and it frequently reverses a conglomerate discount — the tendency of markets to value a diversified group below the sum of its parts because investors who want one business are forced to own all of them. Sanofi explicitly framed its Opella sale as a step toward becoming a pure-play biopharma, freeing it to concentrate on medicines and vaccines rather than consumer health.

The second is capital. A sale converts a business into cash that can pay down debt (deleveraging), fund a turnaround, or be returned to shareholders. Intel used the Altera proceeds to help fund its turnaround; Reckitt paired its Essential Home sale with plans for a special dividend of roughly $2.2 billion to shareholders. The unit becomes fuel for whatever the parent needs more.

The third is pressure, in three forms. Activist investors push boards to break up and sell units they believe the market undervalues inside the group. A regulator can mandate a divestiture as the price of clearing a merger. And a routine portfolio review — the disciplined, periodic question of "does this still fit?" — regularly flags a division that has drifted from the strategy. Any one of these can turn a hold into a sale.

What is a regulatory or antitrust-remedy divestiture?

A regulatory or antitrust-remedy divestiture is a forced sale of assets that a merging company must complete to win clearance from competition regulators. This is the one kind of divestiture the seller does not want to do — it is the price of getting a bigger deal approved. When a proposed merger would concentrate a market too far, agencies such as the U.S. Federal Trade Commission (FTC) or Department of Justice (DOJ) demand that the parties sell overlapping stores, brands, or plants to a qualified third party, so that a viable competitor survives after the merger closes.

The mechanism is a divestiture package: the merging companies assemble a bundle of assets and line up a buyer strong enough to run them as a real competitor. The whole remedy lives or dies on that buyer's credibility and the completeness of the package — regulators and courts scrutinize whether the divested assets can actually stand alone and compete, or whether they are being set up to fail.

The Kroger-Albertsons merger is the teaching case, because the remedy failed. To address antitrust concerns over their $24.6 billion proposed combination (announced October 14, 2022), the parties offered a divestiture package to the grocery wholesaler C&S Wholesale Grocers that, after an April 22, 2024 amendment, grew to 579 stores along with banners and private-label brands. Regulators and state courts found the package an insufficient remedy — doubting C&S could operate the stores as a durable competitor — and blocked the deal. Kroger terminated the merger on December 11, 2024, and with it the divestiture died: no merger, no remedy sale. It is the cleanest illustration that a remedy divestiture is only as good as the buyer behind it.

How does a divestiture process actually run?

A sell-side divestiture runs in four phases — preparation, marketing, diligence and negotiation, and separation — and the hard part is almost always the preparation, because you are extracting a business that was never built to stand alone. Here is the sequence a corp-dev team and its bankers actually follow.

Preparation. Three workstreams start before any buyer sees anything. You define the perimeter — exactly which contracts, employees, assets, and liabilities travel with the unit versus staying with the parent. You build carve-out financials — standalone historical statements for a business that never had its own P&L because it was buried inside the parent's consolidation. And you design the transition service agreements (TSAs) — the schedules under which the parent keeps supplying IT, payroll, procurement, or logistics to the unit for a bridge period after close, because you cannot sever every shared system on day one. This is the sell-side due diligence work that determines whether the process runs smoothly or stalls.

Marketing. With the story assembled, bankers send a short anonymized teaser to a screened buyer list, and interested parties sign a non-disclosure agreement to receive the confidential information memorandum (CIM) — the full sell-side book on the unit. Screening matters: you are about to expose sensitive operating data to parties who may include competitors.

Diligence and negotiation. Buyers run due diligence inside a data room, working through financials, contracts, employee data, and the carve-out and TSA plans, then submit bids. The winning bidder negotiates the sale and purchase agreement (SPA) — price, reps and warranties, indemnities, the TSA terms, and the conditions to close.

Separation. After signing and close, the unit is stood up as an independent company and the TSAs are unwound over months as the buyer builds or migrates its own systems. This post-close entanglement is exactly why a carve-out is harder than a clean whole-company sale — the two companies stay operationally linked long after the check clears. The operational mechanics of running that room — the perimeter file list, the entanglement map, stranded costs — live in the corporate divestiture data room and carve-out data room guides. In energy, where non-core asset sales are constant, the upstream oil-and-gas divestiture data room guide covers the reserve-report and title-data specifics.

The diligence phase is where the data room earns its place: multiple competing bidders each need a different slice of highly sensitive files, which is a permissions problem before it is a storage problem. I run Peony, a data room company used by 6,800+ customers, and this multi-bidder, months-long pattern is exactly what flat per-admin pricing suits — adding another bidder's analyst never changes the bill.

What are real divestiture examples?

The fastest way to internalize the definition is against real, verified, dated deals — each one a cash sale, not a distribution to shareholders. Here are five recent divestitures plus the antitrust case, with the structure named precisely.

• Sanofi → Opella (sale to CD&R). Sanofi sold a 50.0% controlling stake in its consumer-health business Opella (brands including Doliprane, Allegra, Dulcolax) to private-equity firm CD&R at a €16.0 billion enterprise value — roughly 14× 2024 estimated EBITDA. The deal closed April 30, 2025; Sanofi retained a 48.2% stake and France's Bpifrance took 1.8%, and Sanofi received about €10 billion in net cash. The strategic logic: become a pure-play biopharma.
• Intel → Altera (majority-stake sale to Silver Lake). Intel sold a 51% stake in its Altera programmable-chip business to Silver Lake for $4.46 billion, valuing Altera at $8.75 billion — well below the $17 billion Intel paid for it in 2015. The sale closed September 12, 2025; Intel kept a 49% minority stake, and the proceeds fund Intel's turnaround.
• Reckitt → Essential Home (majority-stake sale to Advent International). Reckitt sold a 70% stake in its Essential Home business (Air Wick, Cillit Bang, Mortein) to Advent International at a $4.8 billion enterprise value. Announced July 18, 2025, the deal closed December 31, 2025; Reckitt retained 30% and planned to return about $2.2 billion to shareholders.
• GE Vernova → Proficy (software-unit sale to TPG). GE Vernova sold its Proficy manufacturing-software business to private-equity firm TPG for $600 million, announced September 11, 2025; the sale closed March 2, 2026. This is a sale of a non-core software unit — not a spin-off — and a clean example of a strategic pruning a portfolio for cash.
• Baker Hughes → Precision Sensors & Instrumentation (carve-out sale to Crane). Baker Hughes sold its Precision Sensors & Instrumentation product line (the Druck, Panametrics, and Reuter-Stokes brands) to Crane Company for $1.15 billion in cash. Announced June 2025, the sale closed January 5, 2026; the unit generated roughly $390 million of 2025 revenue. A carve-out sale of an embedded product line to a strategic buyer.

One contrast worth flagging so you can spot the difference in the wild: Unilever's separation of its ice-cream business (the Magnum Ice Cream Company) is a demerger, not a divestiture — it hands shares to existing holders rather than selling to a buyer. If you see "demerger" or "spin-off" in a filing, no cash came in; if you see "sold to" and a buyer's name, it is a divestiture like the five above.

What is the difference between a divestiture and a spin-off?

The difference is cash and who ends up owning the business — and it is the single most useful distinction to keep straight, because the press blurs it constantly. A divestiture is an outright sale of a business unit for cash to a strategic or private-equity buyer: the parent gets paid, an outside buyer takes ownership, and the unit leaves the shareholder base entirely. A spin-off transfers no cash: the parent distributes the subsidiary's shares pro-rata to its own existing shareholders, who wake up owning a new standalone public company alongside their original shares. No buyer, no proceeds, same owners.

The clean test is two questions: did the parent get paid, and did the business leave the shareholders? A divestiture answers yes and yes — money came in, and the shareholders no longer own the unit. A spin-off answers no and no — no money came in, and the same shareholders still own the business, just as a separate stock. Sanofi selling Opella to CD&R for €10 billion is a divestiture; a company handing its shareholders shares of a newly independent subsidiary is a spin-off.

That is deliberately the short version. The full pro-rata mechanics — how a spin-off is executed, how a split-off's elective exchange works, how an equity carve-out IPO fits in, and the Section 355 tax rules that decide whether shareholders get a tax bill — all live in the dedicated spin-off guide. This post's job is the sale side; that post's job is the distribution side. Together they cover the whole "divesting" family, which also sits inside the broader types of mergers and acquisitions taxonomy. And if you are an owner weighing a sale of your own company rather than a corporate parent pruning a division, the business exit planning guide is the right starting point.

This post is general information, not legal, tax, or financial advice — whether a specific transaction is a divestiture, how it is taxed, and how it should be structured are questions for your advisors. All deal values, dates, and statuses are as of August 2026.

Frequently asked questions

What is a divestiture?

A divestiture is the sale or disposal of a business unit, subsidiary, product line, or asset — usually for cash — to a strategic acquirer or a private-equity buyer. Cash comes in to the parent, and the divested business leaves the parent's ownership. That cash-in, business-out shape is what separates a divestiture from a spin-off, where no cash changes hands and the same shareholders keep the business as a new stock. Recent examples include Sanofi selling a 50% controlling stake in Opella to Clayton, Dubilier & Rice (closed April 30, 2025, €16.0 billion enterprise value) and Intel selling a 51% stake in Altera to Silver Lake for $4.46 billion (closed September 12, 2025).

What is the difference between divestiture and divestment?

Divestment is the broad umbrella term for shedding an asset by any means; divestiture is the specific corporate transaction inside it — the sale of a business unit for cash. 'Divestment' also covers financial and ESG portfolio divestment: an investor selling securities, or an institution exiting a country, sector, or fossil-fuel holding on principle. That kind of divestment is a portfolio decision, not a deal. When a company sells a division to a buyer, that is a divestiture. So every divestiture is a form of divestment, but most divestment (an endowment dumping a stock) is not a divestiture. Treat 'divestiture' as the M&A word and 'divestment' as the wider category.

What are the main types of divestitures?

There are six routes. A trade sale (or sell-off) sells the unit outright to a strategic buyer for cash. A carve-out sale disposes of a unit to a private-equity sponsor, often as a standalone platform. An equity carve-out floats a minority stake through an IPO. A spin-off distributes the unit's shares pro-rata to existing shareholders for no cash, and a split-off offers an elective share exchange — both raise no cash and are covered in our spin-off guide. Liquidation or wind-down sells the assets piecemeal and shuts the unit. Finally, a regulatory-remedy divestiture is a forced sale required to clear a merger with antitrust authorities.

Why do companies divest a business unit?

The recurring motives are focus, capital, and pressure. Focus: shedding a non-core unit lets management concentrate on the core and often reverses a conglomerate discount, where the market values a diversified group below the sum of its parts. Capital: a sale raises cash to pay down debt, fund a turnaround, or return money to shareholders. Pressure comes in three forms — activist investors pushing for a breakup, a regulator mandating a sale to clear a merger, and a routine portfolio review flagging a unit that no longer fits. Sanofi framed its Opella sale as becoming a pure-play biopharma; Intel used the Altera proceeds to fund its turnaround. Different motives, same mechanic: sell the unit, redeploy the value.

What is a regulatory or antitrust-remedy divestiture?

It is a forced sale of assets that a merging company must complete to win antitrust clearance. When a merger would concentrate a market too far, agencies like the FTC or DOJ demand the parties sell overlapping stores, brands, or plants to a qualified third party so competition survives. The catch is that the remedy is only as good as the buyer and the package. In the Kroger-Albertsons merger, the parties offered a divestiture package to C&S Wholesale Grocers that grew to 579 stores, but courts found it insufficient and blocked the deal, and Kroger terminated the merger on December 11, 2024 — so the remedy divestiture died with the transaction it was meant to save.

How does a divestiture process actually run?

A sell-side divestiture runs in stages. First comes preparation: define the perimeter (what travels with the unit), build carve-out financials (standalone historicals that never existed inside the parent), and design the transition service agreements (TSAs) that keep the two companies operationally linked after close. Then the marketing phase — a teaser, an NDA, and a confidential information memorandum (CIM) go to a screened buyer list. Buyers run due diligence in a data room, submit bids, and the winner negotiates a sale and purchase agreement (SPA). Finally, separation: standing up the unit as an independent company and unwinding the TSAs. Carve-outs are harder than clean whole-company sales because the perimeter and entanglements have to be untangled first.

What are recent examples of divestitures?

Several 2025-26 deals show the sale mechanic. Sanofi sold a 50% controlling stake in its consumer-health unit Opella to CD&R at a €16.0 billion enterprise value, closing April 30, 2025 and netting Sanofi around €10 billion. Intel sold a 51% stake in Altera to Silver Lake for $4.46 billion, valuing Altera at $8.75 billion, closing September 12, 2025. Reckitt sold a 70% stake in its Essential Home business to Advent International at a $4.8 billion enterprise value, closing December 31, 2025. GE Vernova sold its Proficy software business to TPG for $600 million, closing March 2, 2026. Each is a cash sale, not a spin-off.

What is the difference between a divestiture and a spin-off?

Cash and ownership. A divestiture is an outright sale of a business unit for cash to a strategic or private-equity buyer — the parent gets paid and the unit leaves the shareholder base entirely. A spin-off transfers no cash: the parent distributes the subsidiary's shares pro-rata to its own existing shareholders, who end up owning a new standalone public company alongside their original shares. The test is simple — did the parent get paid, and did the business leave the shareholders? A divestiture is yes-and-yes; a spin-off is no-and-no. Our spin-off guide covers the pro-rata distribution structures, split-offs, and the Section 355 tax rules that make a spin-off tax-free.

What is a carve-out sale to a private-equity firm?

A carve-out sale is a divestiture in which a parent sells a business unit that was embedded inside it — sharing systems, staff, contracts, and financials — to a private-equity sponsor that will run it as a standalone platform. It is harder than selling a self-contained subsidiary because the unit has to be surgically separated: the perimeter defined, standalone carve-out financials built, and transition service agreements written so the parent keeps supplying IT or payroll for a bridge period. Baker Hughes selling its Precision Sensors & Instrumentation line to Crane Company for $1.15 billion (closed January 5, 2026) is a carve-out sale to a strategic; the same shape applies when the buyer is a PE sponsor.

Do you need a data room to run a divestiture?

In practice yes — a divestiture is a document-heavy sell-side process, and buyers expect a real data room, not a shared folder. You are exposing carve-out financials and contracts to multiple competing bidders who must each see a different slice, so granular permissions and visitor groups per bidder are the whole game. Dynamic watermarking deters leaks, and one-click revoke pulls a losing bidder's access the moment they drop out. I run Peony, a data room company used by 6,800+ customers: the Data Room plan is $52 per admin per month annually (dynamic watermarking, Advanced NDA, unlimited storage), Business is $30, and there is a free tier — with analytics and link expiry on every tier.

Related resources

• What Is a Spin-Off? — the no-cash side of the divesting family: pro-rata distributions, split-offs, equity carve-out IPOs, and the Section 355 tax rules.
• Corporate Divestiture Data Room — the operational guide to running a divestiture or carve-out room: the perimeter problem, entanglement map, stranded costs, and TSA schedules.
• Carve-Out Data Room — the carve-out case specifically, from defining what travels with the unit to walling the retained parent off from bidders.
• Upstream Oil & Gas Divestiture Data Room — the energy-sector divestiture room, with reserve reports, title data, and A&D specifics.
• Sell-Side Due Diligence — how sellers prepare the unit, the financials, and the room before buyers arrive.
• Business Exit Planning — for owners weighing a sale of their whole company rather than a corporate parent pruning a division.
• Types of Mergers and Acquisitions — the wider M&A taxonomy that divestitures, spin-offs, and carve-outs sit inside.